A cross-sectional study to assess the drug utilization pattern and pharmacotherapeutic adherence among patients with schizophrenia and quality of life of patient’s caregiver in a tertiary care teaching hospital

Authors

  • Honshil V. Parikh Department of Pharmacology, Narendra Modi Medical College, Maninagar, Ahmedabad, India
  • Bhavesh M. Vyas Department of Pharmacology, Narendra Modi Medical College, Maninagar, Ahmedabad, India
  • Gurusharan H. Dumra Department of Pharmacology, Narendra Modi Medical College, Maninagar, Ahmedabad, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20233907

Keywords:

Schizophrenia, Drug utilization, Adherence, Quality of life, Caregiver

Abstract

Background: Schizophrenia is a chronic severe psychiatric illness affecting nearly 0.4 to 1.4% of people in India. Many newer anti-psychotic drugs are used now-a-days in schizophrenia. Poor adherence to the treatment given to patients of schizophrenia is observed very often. Although, the quality of life of schizophrenia patients is very much compromised; at the same time, quality of life of the caregiver is also compromised.

Methods: A cross-sectional Observational study was conducted among patients already diagnosed with Schizophrenia and on treatment, after ethical approval. Data relevant to study variables was collected in a pre-designed case record form. Evaluation of drug utilization pattern was done by WHO core drug prescribing indicators. Medication adherence was assessed through modified Morisky scale. Quality of life of relative or caregiver was assessed through WHO-QOL BREF questionnaire scale.

Results: Patients of 18 years and above were enrolled. Among them, average age was 35.8±5.5 years. In my study, female patients were 64.7% and male patients were 35.3%. Average number of drugs per prescription was 3.8. Drugs prescribed by generic name were around 86.2%. Around 56.9% of drugs were prescribed from national list of essential medicines. Atypical antipsychotics were prescribed in 32% of all prescriptions for Schizophrenia; Whereas Benzodiazepines were prescribed in 19% of all prescriptions. Average Medication adherence score using MMS scale was 3.7±2.2. Patients with high adherence to the medications prescribed were nearly 71% and patients with low adherence to the medications prescribed were 29%. Mean total WHOQOL-BREF score was 75.2±6.5 out of 120.

Conclusions: Most prescribed class of drugs was atypical anti-psychotics. Pharmacotherapeutic adherence among patients with schizophrenia was relatively high. Quality of life of patients’ relative or caregiver was impaired to some extent, more impaired in physical health and social relationships domain.

References

Tripathi RK, Gajbhiye S, Jalgaonkar S, Khatri N, Sayyed M, Parkar S. Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India. Cureus. 2022;14(3):e23378.

Hivale NS, Kulkarni MD, Athawale SS. Drug utilization study in schizophrenia patients in outpatient department of psychiatry: an observational prospective study. Int J Basic Clin Pharmacol. 2020;9(3):475-9.

Thakkar KB, Jain MM, Billa G, Joshi A, Khobragade AA. A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital. J Clin Diagnostic Res. 2013;7(12):2759-64.

Caqueo-Urízar A, Urzúa A, Mena-Chamorro P, Fond G, Boyer L. Adherence to antipsychotic medication and quality of life in Latin-American patients diagnosed with Schizophrenia. Patient Prefer Adherence. 2020;14:1595-604.

Acosta FJ. Medication adherence in schizophrenia. World J Psychiatr. 2012;2(5):74.

Kikkert MJ, Dekker J. Medication adherence decisions in patients with schizophrenia. Prim Care Companion J Clin Psychiatr. 2017;19(6).

Misdrahi D, Petit M, Blanc O, Bayle F, Llorca PM. The influence of therapeutic alliance and insight on medication adherence in schizophrenia. Nord J Psychiatr. 2012;66(1):49-54.

Prakash J, Mondal A, Ali MS, Mahto J. Quality of Life in the Caregivers of Schizophrenic Patients. East J Psychiatry. 2021;16(1-2):68-72.

Caqueo-Urízar A, Alessandrini M, Urzúa A, Zendjidjian X, Boyer L, Williams DR. Caregiver’s quality of life and its positive impact on symptomatology and quality of life of patients with schizophrenia. Health Qual Life Outcomes. 2017;15(1):76.

Rudraraju RKR, Molli S. A Comparative Study of Quality of Life in Caregivers of Patients with Schizophrenia and Mood Disorder at a Tertiary Care Psychiatric Hospital at Visakhapatnam. J Evid Based Med Healthc. 2021;8(23):1922-6.

Ribé JM, Salamero M, Pérez-Testor C, Mercadal J, Aguilera C, Cleris M. Quality of life in family caregivers of schizophrenia patients in Spain: caregiver characteristics, caregiving burden, family functioning, and social and professional support. Int J Psychiatr Clin Pract. 2018;22(1):25-33.

Setiawati NM. Differences in Sociodemographic Characteristics of Schizophrenia Patients between Rural and Urban Areas in Badung Regency. Warmadewa Med J. 2020;5(2):76-84.

Shaifali I, Karmakar R, Chandra S, Kumar S. Drug utilization audit of antipsychotics using WHO methodology : recommendations for rational prescribing. Int J Basic Clin Pharmacol. 2019;7(10):2021-7.

Ilyaz M, Baig MMA, Ramakrishna, Quadir MA, Fathima M, Khan SAS. Drug utilization study of antipsychotics and its common ADR’S in the psychiatry OPD of OHRC. Int J Pharm Pharm Sci. 2014;6(9).

Chaudhari B, Saldanha D, Kadiani A, Shahani R. Evaluation of treatment adherence in outpatients with schizophrenia. Ind Psychiatry J. 2017;26(2):215-22.

Downloads

Published

2023-12-26

How to Cite

Parikh, H. V., Vyas, B. M., & Dumra, G. H. (2023). A cross-sectional study to assess the drug utilization pattern and pharmacotherapeutic adherence among patients with schizophrenia and quality of life of patient’s caregiver in a tertiary care teaching hospital. International Journal of Basic & Clinical Pharmacology, 13(1), 141–146. https://doi.org/10.18203/2319-2003.ijbcp20233907

Issue

Section

Original Research Articles